COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Spyral HTN on med

Purpose of Study

The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications

Trial Status


Eligibility Criteria

Individual is >20 and <80 years old at time of enrollment (consent), has an office systolic blood pressure >150mmHG and<180mmHg and an office diastolic blood pressure >90mmHg, has a valid 24 hour ambulatory blood pressure average of >140mmHg and <170mmHg

Duration of Participation

Approximately 3 years

Contact Name: Jennifer Young, RN

Contact Phone: 515-633-3841

Contact Email: